Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07133958) titled 'A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC' on Aug. 14.

Study Type: Observational [Patient Registry]

Primary Sponsor: Zhujiang Hospital

Condition: Oral Squamous Cell Carcinoma (OSCC) Oropharyngeal Squamous Cell Carcinoma (SCC)

Recruitment Status: Recruiting

Date of First Enrollment: July 11, 2023

Target Sample Size: 35

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07133958

Published by HT Digital Content Services with permission from Health Daily Digest....